NovoCure (NVCR) Shares Issued (2014 - 2026)

NovoCure's Shares Issued history runs 13 years deep, the most recent figure standing at $390000.0 for Q1 2026.

• In Q1 2026, Shares Issued fell 92.57% year-over-year to $390000.0; the TTM figure through Mar 2026 stood at $146000.0 (down 98.46% YoY), while the FY2025 annual figure was $3.7 million, down 11.9% from the prior year.
• Shares Issued came in at $390000.0 for Q1 2026 at NovoCure, up from -$2.4 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $8.5 million in Q4 2023 to a low of -$2.4 million in Q4 2025.
• A 5-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 244.75% in 2023 and fell as far as 498.46% in 2023.
• NovoCure's Shares Issued stood at $2.5 million in 2022, then soared by 244.75% to $8.5 million in 2023, then sank by 76.9% to $2.0 million in 2024, then tumbled by 221.24% to -$2.4 million in 2025, then soared by 116.39% to $390000.0 in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $390000.0, -$2.4 million, and $2.1 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison